Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Toxicology and Applied Pharmacology|June 17, 2008
Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cellsTheodore Sarafian, Cindy Montes, Airi Harui, et al.
Arthritis Research & Therapy|January 18, 2019
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
Arthritis Care & Research|May 26, 2017
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled TrialsRajaie Namas, Donald P Tashkin, Daniel E Furst, et al.
The American Journal of Medicine|May 3, 2011
Adverse events during the Scleroderma Lung StudyDaniel E Furst, Chi-Hong Tseng, Philip J Clements, et al.
Drug and Alcohol Dependence|January 9, 2008
Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected menChun Chao, Lisa P Jacobson, Donald Tashkin, et al.
Annals of the Rheumatic Diseases|December 3, 2014
Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosisDonald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, et al.
Cancer Causes & Control : CCC|November 18, 2008
Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphomaChun Chao, Lisa P Jacobson, Donald Tashkin, et al.
The Lancet. Rheumatology|September 25, 2023
Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trialsElizabeth R Volkmann, Donald P Tashkin, Richard Silver, et al.
American Journal of Respiratory and Critical Care Medicine|November 4, 2017
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Suzanne Kafaja, Philip J Clements, Holly Wilhalme, et al.
Pageof 10